Report Highlights
The global market for agricultural biotechnology is estimated to increase from $79.9 billion in 2023 to reach $119.6 billion by 2028, at a compound annual growth rate (CAGR) of 8.4% from 2023 through 2028.
Report Includes
- 28 data tables and 38 additional tables
- An overview of the global market landscape related to the agricultural biotechnology
- In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by type, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of agricultural biotechnology companies, the effect of research funding, and the third-party quality evaluation systems of agricultural biotechnology
- Description of emerging technologies, advantages and risks associated with agricultural biotechnology and identification of market drivers, restraints and other forces impacting the global market
- Evaluations of the roles that key agricultural biotechnology tools will play in the marketplace, such as next-generation DNA sequencing, biochips, RNA interference, and synthetic biology tools and genome editing tools,
- Coverage of new discoveries in agricultural sciences, rapid technological developments in the industry, FDA and international regulations, details of recent regulatory reforms and insights into government initiatives and fundings
- Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global agricultural biotechnology
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including BASF SE, Corteva Inc., Thermo Fisher Scientific Inc., Valent BioSciences, AgBiome Inc., and Syngenta AG
Report Scope
The report provided an updated review of the global agricultural biotechnology market, focusing on its product types and end uses. Definitive and detailed assessments and forecasts of the worldwide agricultural biotechnology market are provided, followed by a detailed analysis of regions, countries, and key market players.
The global agricultural biotechnology market by product type is segmented into biotech seeds, biologicals, and biotechnology tools. The market is segmented by end use into plants, animals, and microbes.
The market size and estimations are provided in terms of value ($ Millions); 2022 serves as a base year, and the market forecast is provided from 2023 to 2028. Regional-level market sizes for product type and end-use segments are also provided.
The report also discusses the major players across each regional agricultural biotechnology market. In addition, it explains the global agricultural biotechnology market’s primary drivers, regional dynamics, and current trends across the industry. The report concludes with a detailed focus on the vendor landscape and includes complete company profiles of the major players in the market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||||||
| Base year market size | $79.9 billion | ||||||||||||||||||||
| Market size forecast | $119.6 billion | ||||||||||||||||||||
| Growth rate | CAGR of 8.4% for the forecast period of 2023-2028 | ||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||
| Segments covered | Type, End-use, and Region | ||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Latin America and Middle East & Africa (LAMEA) | ||||||||||||||||||||
| Countries covered | U.S., Canada, Spain, Portugal., China, India, Brazil, and Argentina | ||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for agricultural biotechnology products should grow from $50.5 billion in 2019 to $72.2 billion by 2024 with a compound annual growth rate (CAGR) of 7.4% for the period of 2019-2024.
Report Includes
- 32 data tables and 60 additional tables
- Detailed review of the global markets for agricultural biotechnology and other emerging technologies
- Analyses of the global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Discussion of key agricultural biotechnology tools such as next generation DNA sequencing, biochips, RNA interference, synthetic biology tools and genome editing tools, and assaying their role in enhancing the marketplace
- Underlying market opportunities for biotechnology tools, genomic-enabled products, and biotech seeds enhancing growth for the coming five years
- Key merger and acquisitions, joint ventures, and alliances within the large biotechnology companies, allowing them to participate in the upside of new genomics technologies that will enhance their breeding, seed development, and biologics programs
- Company profiles of market leading participants, Ajinomoto Co. Inc., Basf AG, Cibus Inc., Novozymes A/S, Oxford Nanopore Technologies Ltd., and Qiagen NV
Report Highlights
The global market for agricultural biotechnology reached $29.2 billion in 2016. This market should reach $32.1 billion in 2017 and $53.7 billion in 2022, with a compound annual growth rate (CAGR) of 10.8%.
Report Includes
- An overview of the global markets for agricultural biotechnology and related emerging technologies
- Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Segmentation of the markets by product type (microarrays, DNA sequencing, biochips, synthetic biology-enabled and transgenic seeds), by crop type, and by geography
- Information on growth driving forces, market applications, industry structure and competitive dynamics
- Analysis of key technologies and products to determine the present and future status of the market
- Profiles of major players in the industry
Report Highlights
The global market for agricultural biotechnology reached $26.4 billion in 2013 and $27.8 billion in 2014. This indication is expected to reach $46.8 billion in 2019, registering a compound annual growth rate (CAGR) of 11.0% over the next five years.
Report Includes
- An overview of the global markets for agricultural biotechnology.
- Analyses of global market trends, with data from 2013, 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Segmentation of the markets by product type (microarrays, DNA sequencing, biochips, synthetic biology-enabled and transgenic seeds), by crop type, and by geography.
- Information on growth driving forces, market applications, industry structure and competitive dynamics.
- Analysis of key technologies and products to determine the present and future status of the market.
Report Highlights
The global market for agricultural biotechnology was $13.7 billion in 2011 and is estimated to grow to $14.4 billion in 2012, growing at a compound annual growth rate (CAGR) of 11.4%, to reach a forecast value of nearly $24.8 billion in 2017.
Related Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Molecular Farming: Global Markets
The global market for molecular farming is expected to grow from $454.1 million in 2023 and projected to reach $916.3 million by the end of 2028, at a CAGR of 15.1% during the forecast period of 2023 to 2028.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More